Form 4: TransMedics Group CFO Stephen Gordon Reports Acquisition of Shares and Stock Options

Stephen Gordon, CFO of TransMedics Group, reports the acquisition of restricted stock units and stock options.

Summary

• On February 23, 2024, Stephen Gordon, the Chief Financial Officer of TransMedics Group, Inc. (TMDX), reported transactions involving the company's securities.
• Gordon acquired 12,127 restricted stock units (RSUs), each representing a contingent right to receive one share of TransMedics Group's common stock.
• He also acquired 18,690 stock options with an exercise price of $83.14.
• These options vest monthly at a rate of 2.0833% starting February 23, 2024, and will be fully vested by February 23, 2028, contingent upon continued service.
• Following these transactions, Gordon directly owns 25,202 shares of common stock and 18,690 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by the CFO suggests confidence in the company's prospects, but it's a routine filing.

Positives

• The acquisition of RSUs and stock options by the CFO signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the stock options, contingent on continued service, suggests an expectation of long-term commitment from the CFO.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in the company's securities. This filing indicates the CFO's continued investment in TransMedics Group.

Stakeholder Impact

• The transactions may have a minor positive impact on shareholder sentiment due to the CFO's increased stake in the company.

Key Dates